CareMax Management

Management criteria checks 2/4

CareMax's CEO is Carlos de Solo, appointed in May 2011, has a tenure of 13.67 years. total yearly compensation is $3.39M, comprised of 19.2% salary and 80.8% bonuses, including company stock and options. directly owns 5.65% of the company’s shares, worth $5.39K. The average tenure of the management team and the board of directors is 2.8 years and 2.9 years respectively.

Key information

Carlos de Solo

Chief executive officer

US$3.4m

Total compensation

CEO salary percentage19.2%
CEO tenure13.7yrs
CEO ownership5.6%
Management average tenure2.8yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

Aug 14
US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Jun 20
CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

May 13
Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Mar 11
Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

CareMax: Numbers Are Strong, Compelling Value On Offer

Sep 16

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

Aug 09

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

Jul 02

CEO Compensation Analysis

How has Carlos de Solo's remuneration changed compared to CareMax's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$783m

Mar 31 2024n/an/a

-US$645m

Dec 31 2023US$3mUS$650k

-US$683m

Sep 30 2023n/an/a

-US$207m

Jun 30 2023n/an/a

-US$126m

Mar 31 2023n/an/a

-US$103m

Dec 31 2022US$3mUS$650k

-US$38m

Sep 30 2022n/an/a

-US$52m

Jun 30 2022n/an/a

-US$44m

Mar 31 2022n/an/a

-US$25m

Dec 31 2021US$2mUS$419k

-US$7m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

US$12m

Mar 31 2021n/an/a

US$6m

Dec 31 2020US$3mUS$112k

US$8m

Sep 30 2020n/an/a

US$7m

Dec 31 2019US$3mUS$48k

US$6m

Compensation vs Market: Carlos's total compensation ($USD3.39M) is above average for companies of similar size in the US market ($USD642.68K).

Compensation vs Earnings: Carlos's compensation has been consistent with company performance over the past year.


CEO

Carlos de Solo (45 yo)

13.7yrs

Tenure

US$3,386,890

Compensation

Mr. Carlos A. de Solo is a Co-Founder of CareMax Medical Group, L.L.C., and serves as President, Chief Executive Officer and Director since May 2011. Mr. de Solo has experience in the healthcare industry....


Leadership Team

NamePositionTenureCompensationOwnership
Carlos de Solo
Co-Founder13.7yrsUS$3.39m5.65%
$ 5.4k
Kevin Wirges
Executive VP3.6yrsUS$1.35m0.14%
$ 138.0
Alberto de Solo
Executive VP & COO13.7yrsUS$1.82m2.55%
$ 2.4k
Erick Fernandez
Chief Accounting Officer3yrsno datano data
Mark Llorente
Chief Administrative Officer & Head of MSO Operations1.8yrsno datano data
Roger Ou
SVP of Finance & Investor Relationsno datano datano data
Meredith Longsworth
Senior VP2.8yrsno datano data
Teresa McMeans
Chief Compliance Officer2.8yrsno datano data
Niberto Moreno
Chief Medical Officer & President of Caremax MSOno datano datano data
Nicole Cable
Chief Experience Officer2.8yrsno datano data
Michael Jarjour
Chief Digital Officer2yrsno datano data
Paul Rundell
Chief Restructuring Officerless than a yearno datano data

2.8yrs

Average Tenure

45yo

Average Age

Experienced Management: CMAX.Q's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Carlos de Solo
Co-Founder13.7yrsUS$3.39m5.65%
$ 5.4k
Richard Barasch
Advisor to the Board2.9yrsUS$565.56kno data
Edward Borkowski
Independent Directorless than a yearno datano data
Ralph de la Torre
Director2.2yrsUS$205.00k15.79%
$ 15.1k
Kevin Berg
Independent Director2.2yrsUS$216.35k0.011%
$ 10.1
Bryan Cho
Independent Director3.5yrsUS$235.00k0.47%
$ 449.7
Jose Rodriguez
Independent Chairman3.6yrsUS$322.50k0.036%
$ 34.5
Vincent Omachonu
Independent Director3.6yrsUS$205.00k0.026%
$ 24.7
Ryan O'Quinn
Independent Director2.2yrsUS$225.00k0.011%
$ 10.1

2.9yrs

Average Tenure

57yo

Average Age

Experienced Board: CMAX.Q's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 05:26
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CareMax, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian TanquilutJefferies LLC
Jessica TassanPiper Sandler Companies
Gary TaylorTD Cowen